IWS, do not forget that IMET's Ph 2 MF trial hasn't even begun!! How can the FDA grant an FTD status this early? Once the Ph 2 starts, which a global multi-center trial and time-consuming to begin implementation, the FDA will move if Geron/JNJ has already applied for the grant of the status. At this point, I blame the lack of transparency on the part of Geron management to its shareholders. It is also intriguing to me as to why Geon can not come out with update to us that they are say 80% on the way to begin the Ph 2?!! The FDA lifted the hold and did its job; now, the ball is in Geron's court.
Perhaps one reason but not the sole reason. True, those traders who rarely want to look at company or its product fundamentals sing the song of "only one product company"; but, for those, who can dive deep, it's nonsence in case of Geron. But, then the former are like parking spots on a downtown street and the latter are like garages at home!! Who cares what the foolish traders do!!!
BM's complaint of "veil of silence" is intriguing!! At least, the management can make an announcement that helps stop speculation!! From that point of view, it has failed.
terrier, your post above gives a pretty good idea to me how WS trading goes on. Of course, the manner in which it goes on must depend on whether a security belongs to NYSE, AMEX NASDAQ or over-the-counter exchange. And, I agree with you that exodus of shorts will follow some significant news, not w.r.t. announcement of results of the 33 MF patients tried at Mayo but what comes out of J&J or solid news w.r.t. FTD or multi-applications of IMET. The announcement of Ph 2 trial actual start may not bring the exodus. Thanks for the time you take in responding with credible insider knowledge about trading activity and your deep understanding.
Thanks, terrier, you have explained your answer to my question pretty well. It looks like you have been in this business working either at one of the trading houses or with a company like Merrill Lynch involved in securities trading.This also means that a retail trader can't move and manipulate the market, it must be these institutional traders who do that.
Incyte has other products in the pipe line and it's WS favorite (meaning, some WS biggies have invested in it). That's not the case with Geron. And, IMET, the only Geron product, is still not in Ph 2
to those who know: If the Bid Volume is 13000 and Ask Volume is 6000 at any time and a few seconds later the Bid Volume changes to 9000 and the Ask Volume remains the same at 6000, where does the 4000 (=13000 - 9000) shares that are sold come from?!!
Just review very carefully trade sizes at each significant SP drop and rise!! I have no doubt in my mind that there is SP manipulation by WS players. What you are expecting is not going to happen until the MF trial is well into Ph 2 and the FDA grants it an FTD not any other news (except, of course, another major pharma partnership or takeover). In absence of an FTD grant, with the current situation, the SP may remain low and into trading ranges. These WS crooks make money through frequent in and out moves, using tools they have available in the modern-day market. and the MM love that!!
Of course, two downthumbs I got on my post above shows that the WS crooks reside on this board and not all visitors of this board are just poor retail traders!!!
Mail, there is one advantage to management members for keeping the SP low: They can award themselves cheaply priced stock options!! BlackM doesn't seem to have considered that!!!
Black, your complaints to change the management done through hundreds of your posts on this board has none and will have no effect and you know that very well. If after committing almost a billion dollars, J&J doesn't want to replace Scarlett, your vocal expression of frustration is not going to help. So too if the funds that hold millions of shares in this company do not want any management change at this point, Scarlett is a fact of life for us retail shareholders. Then why are you wasting all your efforts? In my view, you have no choice as an insignificant shareholder, like I am, but to live with what we got!! It's fruitless to keep hammering the same point and get unnecessary headaches..
Also, IWS, traditionally, the SP doesn't get lifted substantially until Ph 3 for clinical stage biotechs. In Geron's case , due to JNJ involvement, it may happen earlier if an FTD or BTD status is granted. I do not expect that before well into Ph 2 of the MF trial and other evidences are gathered that show that IMET will have potentially lucrative multiapplications. Until then, WS dogs who are seasoned manipulators will keep playing the stock to make some money while many fools on this board keep speculating passing on stupid theories of their own!!
rattlebug, while you are theoretically right, you are living in a dream world if you believe that there is no manipulation by WS crooks and that that has a prominent effect on the current trading and SP of Geron!!
terrier, thanks for elaborating what I really stated in my original post. This is not a game played by retail traders, it's being played by WS crooks. And, neither SEC nor you are going to stop it!! Just live with these jerks!!
The stock trading is manipulated currently to keep the SP low so that those given chance to accumulate will get a decent profit when the SP jumps up, perhaps within a month and when the shorts rush frantically to cover. All other talk and Bollinger-band or wedge theory garbage doesn't apply to overall trading of this stock. WS controls and not mom-and-pop trader!!
Oops, please correct my spelling of pundit in my posts above. Thanks.
Of course, I am no pundit myself!!!
A pandit is an expert, having deep knowledge and understanding and has developed intuitive ability.